Based on the sites of frequent allelic loss in hepatocellular carcinoma, ®ve normal human chromosomes (2, 4, 5, 10 and 16) were transferred individually into a telomerase-positive human hepatocellular carcinoma cell line, Li7HM, by microcell-mediated chromosome transfer (MMCT). Chromosome 10, but not the others, repressed telomerase activity immediately and stopped cell growth after 50 population doublings (PDs). Loss of the transferred 10p loci resulted in the emergence of revertant cells that continued to proliferate and expressed telomerase activity, suggesting the presence of a telomerase repressor gene on this chromosomal arm. Transfer of a series of de®ned fragments from chromosome 10p successfully narrowed down the responsible region: a 28.9-cM region on 10p15 (between WI-4752 and D10S249), but not a 26.2-cM region (between D10S1728 and D10S249), caused repression of telomerase activity and progressive telomere shortening. A strong correlation between the expression level of telomerase catalytic subunit gene (hTERT) and telomerase activity was observed. These ®ndings suggest that a novel telomerase repressor gene which controls the expression of hTERT is located on the 2.7-cM region (between WI-4752 and D10S1728) on chromosome 10p15.1. Oncogene (2001) 20, 828 ± 835.
Introduction
Telomerase is an enzyme that adds repeated hexameric sequences (TTAGGG)n to chromosome ends. The telomerase holoenzyme has the RNA component (hTR) containing an internal sequence complementary to the telomeric repeat sequence (Feng et al., 1995) and a catalytic protein component (hTERT) that synthesizes telomeric DNA directly onto the ends of chromosomes by reverse transcription of the RNA template (Meyerson et al., 1997; Nakamura et al., 1997) . Telomerase activity is detected in most tumor cells and immortal cells in culture, while most adult tissues lack this activity (Counter et al., 1992; de Lange, 1994; Kim et al., 1994) . Microcell-mediated transfer of a speci®c normal chromosome into cancer cells results in repression of telomerase activity (Ohmura et al., 1995) . These observations have led to the hypothesis that normal cells express genes that repress telomerase activity (Oshimura and Barrett 1997) . One approach to precisely map telomerase repressor genes to speci®c chromosomal regions is to identify loss of the chromosomal loci in cells that reexpress telomerase activity from suppressed hybrids (Wright et al., 1996) . Another, more direct approach, and the one taken in the present study, is to identify subchromosomal fragments that cause repression of telomerase activity (Tanaka et al., 1998) . These approaches led to the identi®cation of a putative senescence-inducing gene on chromosome 3p14.2-p21.1 that represses telomerase activity in human renal cell carcinoma cells through down-regulation of hTERT expression (Tanaka et al., 1998; . In this study, we introduce single human chromosomes 2, 4, 5, 10, 10p or 16 as well as chromosome 10p subfragments (10pF) into a hepatocellular carcinoma cell line by MMCT, and examine the eect on cell growth, morphology, telomerase activity, telomere length and expression of telomerase components. Our results map a novel telomerase repressor gene that controls the expression of hTERT to a 2.7-cM region on 10p15.1.
Results

Mapping of a telomerase repressor gene to chromosome 10p
A single copy of human chromosomes 2, 4, 5, 10 or 16 was introduced into the hepatocellular carcinoma cell line Li7HM. From four MMCT experiments, 16 ± 23 drug-resistant clones for each chromosome were randomly isolated and passaged (Table 1 ). All clones that formed following transfer of chromosomes 2, 4, 5 or 16 resembled the parental cells with telomerase activity, both initially and after prolonged passages (data not shown). These microcell hybrids had cell morphology and growth property similar to the parental cells ( Figure 1 , Table 1 ). Ten of 20 Blastcidine S Hydrochloride (BSH)-resistant clones formed by transfer of chromosome 10 resembled the parental cells with cell growth and telomerase activity both initially and after prolonged passages (namely, early revertants). In contrast, the remaining 10 BSH-resistant clones (50%) were repressed in telomerase activity and underwent growth arrest after approximately 50 PDs ( Figure 1 , Table 1 ). Five revertant clones emerged after a growth arrest and were isolated (Table 1) . These revertants (namely, late revertants) continued to proliferate similar to the parental cells and expressed telomerase activity. We examined the revertant clones for the status of a pSV2bsr-tagged chromosome 10 bȳ uorescence in situ hybridization (FISH) (Figure 2a , b). All ®ve late revertants, as well as early revertants that did not undergo growth arrest, retained the transferred chromosome 10q, on which the pSV2bsr was integrated, but lost the majority of transferred 10p ( Figure  2b ).
We next used A9 cells containing only chromosome 10p (Figure 3a) . To con®rm the presence of a tumor and/or telomerase suppressor gene on chromosome 10p, we introduced this 10p fragment to Li7HM cells. Five of 20 BSH-resistant clones formed by transfer of chromosome 10p resembled the parental cells with cell growth and telomerase activity both initially and after prolonged passages. The remaining 15 BSH-resistant clones (75%) were repressed in telomerase activity and underwent growth arrest after approximately 50 PDs ( Figure 1 , Table 1 ).
Then A9(bsr10p) was used to generate radiation microcell hybrids containing smaller fragments of 10p. Chromosomal in situ suppression (CISS) hybridization using Alu-PCR probe prepared from the mouse A9 cells containing fragments of 10p revealed that one clone contained two distinct 10p region, 10p11-p12 and 10p14-p15 (Figure 3b ). This radiation hybrid (termed 10pF hybrid) was introduced into Li7HM cells and nine microcell hybrids were isolated (Table 1) . Five of nine microcell hybrids resembled the parental cells with cell growth and telomerase activity both initially and Table 1 ). These hybrids showed a remarkable morphological change (¯at to round), when compared with the parental cells (data not shown).
Fine mapping to 2.7 cM region on 10p15.1
Previous MMCT and loss of heterozygosity (LOH) data on tumor suppressor genes on chromosome 10p (Ittmann, 1996; Kimmelman et al., 1996 Voesten et al., 1997; Ichimura et al., 1998; Kon et al., 1998; Robertson et al., 1999) indicate that a most probable region is located on 10p15. Therefore, we decided to introduce chromosome fragments derived from 10p15 region, termed B1, D6 and B18 (Murakami et al., 2000) individually into the Li7HM cells. These human chromosome 10 fragments were de®ned by STS analyses (Figure 5a ) and CISS hybridization ( Figure  5b ): B1, 28.9-cM between WI-4752 and D10S249; D6, 26.2-cM between D10S1728 and D10S249; and B18, 17.3-cM between D10S189 and D10S249. Twenty-four, 17 and 12 G418-resistant clones were obtained for B1, D6 and B18 fragments, respectively. All of these clones, as well as nine independent subclones of parental Li7HM cells, were examined for telomerase activity. All nine Li7HM subclones had detectable telomerase activity, as did all microcell hybrid clones derived from the transfer of fragments D6 and B18 (Table 2) . However, seven out of 24 microcell hybrid clones generated by the transfer of fragment B1 exhibited repression of telomerase activity at early passages ( Figure 6a , Table 2 ). The presence of B1 fragment in these telomerase repressed microcell hybrids was con®rmed by microsatellite assays with CHLC84C03, D10S1649 and D10S1712 markers (data not shown). Telomerase activity was reactivated during subsequent culture to late passages (Figure 6a ), presumably due to loss of the responsible region on the B1 fragment, as were the cases with transfer of chromosome 10, 10p and 10pF.
Terminal restriction fragment (TRF) lengths of the parental Li7HM cells and two B1 hybrids that exhibited telomerase repression were examined by Southern blotting (Figure 6b ). The mean TRF of these two clones (B1-1 and B1-3) became gradually shorter, reaching 5.3 and 4.3 kb at 28 and 29 PDs after MMCT, respectively. This was markedly shorter than the mean TRF of parental Li7HM cells, about 8 kb. At 116 PDs in B1-1 clone and 118 PDs in B1-3 clone, when the telomerase activity became positive, the TRF lengths were longer than those at early passages (Figure 6b ). This demonstrated that the repression of telomerase activity in B1 hybrids caused the reduction in TRF lengths or shortening of telomeres. These results suggest that the 2.7-cM region on 10p15.1 (between WI-4572 and D10S1728), which is present in B1 but absent in D6 and B18 fragments, is critical to telomerase repression in Li7HM cells (Figure 5a ).
Repression of hTERT expression
We examined the expression of the three known human telomerase components in the early and late passage of B1 hybrids using RT ± PCR analysis. No correlation between the expression levels of either hTR or telomerase-associated protein 1 (TEP1) (Harrington et al., 1997; Nakayama et al., 1997) and telomerase activity was detected (Figure 7) , demonstrating that the expression levels of these genes are not crucial for the control of telomerase activity. In contrast, RT ± PCR analysis of hTERT revealed a strong correlation between its mRNA expression and telomerase enzymatic activity: hTERT mRNA was detected in telomerase-positive parental Li7HM cells and revertant B1 hybrids, but not in telomerase-negative microcell hybrids (Figure 7 ). This suggests that substantial down-regulation of hTERT gene expression occurs following the transfer of chromosome 10p15.1.
Discussion
Telomerase activity is detected in most human cancers and immortalized cells (Counter et al., 1992; de Lange, 1994; Kim et al., 1994) . We and others have reported previously that activation of telomerase occurs during the multistage development of human hepatocellular carcinomas (HCCs) Miura et al., 1997) . These ®ndings indicate that loss of one or more repressors of telomerase activity may occur during multistage carcinogenesis and is associated with cellular immortality. Previous ®ndings by MMCT have indicated the presence of repressors at chromosome 3p, and the loss of function plays a role of the development of renal cell carcinoma and breast cancer (Tanaka et al., 1998; Cuthbert et al., 1999) . In this study, we showed that a novel telomerase repressor gene in HCC that negatively regulates the expression of hTERT is located within a 2.7-cM region on 10p15.1 between the markers WI-4752 and D10S1728. The simplest scenario for regulating hTERT gene expression may be that a protein encoded by the telomerase repressor gene on 10p15.1 acts directly as a transcriptional repressor of hTERT. Alternatively, some other factors or mechanisms may mediate this activity. The promotor region of hTERT gene was recently cloned Figure 4 Telomerase activity in parental Li7HM cells and microcell hybrid clones. TRAP assays were carried out using cell lysate equivalent to 10 3 , 10 2 and 10 cells. The speci®city of the telomerase signals was ensured by including RNase. Li7(10pF), microcell hybrid containing a 10pF; Rev (10pF), microcell hybrid containing a 10pF that escaped from telomerase repression Oncogene Telomerase repressor gene on 10p15.1 A Nishimoto et al and characterized (Cong et al., 1999; Horikawa et al., 1999; Takakura et al., 1999) . Of great interest will be to examine whether and how the telomerase repressor gene on 10p15.1 regulates hTERT gene transcription. Steenbergen et al. (1996) reported that in the process of in vitro immortalization of human keratinocytes by human papillomavirus (HPV) types 16 and 18, a correlation was evident between the activation of telomerase and allelic loss at either chromosome 3p or 10p. These chromosomal arms are the ones on which our previous and current studies mapped the telomerase repressor genes. These ®ndings may suggest a functional relationship between the telomerase repressor genes on 3p and 10p, which deserves further investigation. We found that human chromosome 5 also carries telomerase repressor gene (Kugoh et al., manuscript in preparation) . It is likely that multiple genes function in normal human somatic cells to tightly repress the telomerase activity, at least some of which can control hTERT expression.
LOH at 10p15 is frequently observed in various human cancers, including gliomas, melanomas and prostate cancers. Two small regions of LOH in gliomas were almost identical to the region identi®ed in this study (Kimmelman et al., 1996; Kon et al., 1998) . The telomerase repressor gene at 10p15.1 may therefore be implicated in pathogenesis of these types of cancers.
Characterization of the telomerase repressor gene will facilitate understanding of molecular mechanisms of telomerase regulation and its functional relationship to the other telomerase repressor genes at chromosome 3p and 5. Cloning of the telomerase repressor gene on 10p15.1 will require further functional assays using smaller DNA fragments. An example of this positional cloning approach is introduction of B1-derived fragments obtained by targeted deletions or telomere truncation in chicken DT40 cells with a high homologous recombination rate (Dieken et al., 1996; Kuroiwa et al., 1998) .
Materials and methods
Cell lines
Mouse A9 cells containing a single human chromosome 2, 4, 5, or 10 tagged with the pSV2bsr marker [A9(bsr2), A9(bsr4), A9(bsr5) and A9(bsr10), respectively; Kugoh et al., 1999] or containing a chromosome 16 tagged with the pSV2neo marker (A9(neo16); Koi et al., 1989) were used as human chromosome donors. Cells were maintained in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS), 100 units/ml penicillin, 100 mg/ml streptomycin and 3 mg/ml BSH (Funakoshi) for the BSHresistant (bsr) clones or 800 mg/ml G418 (Life Technologies, Inc.) for the neomycin-resistant (neo) clones. Chinese hamster ovary-human microcell hybrids B1, D6 and B18 carried human chromosome 10p fragments tagged with a neomycinresistance gene as the only human chromosomal material (Murakami et al., 2000) . These cell lines were grown in F12 medium supplemented with 10% FCS and 800 mg/ml of G418. A highly metastatic human hepatocellular carcinoma cell line, Li7HM, established from malignant tissue from a patient with hepatocellular carcinoma (Hirohashi et al., 1979; Osada et al., 1996) .
Microcell-mediated chromosome transfer (MMCT)
Mouse A9 cells containing pSV2bsr-tagged human chromosomes 2, 4, 5, 10, 10p fragment or a pSV2neo-tagged human chromosome 16 were cytogenetically characterized before MMCT. Chinese hamster ovary cells containing a pSV2neo-tagged human chromosome 10p15 fragment were prepared by the same method (Murakami et al., 2000) . These human chromosomes and fragments were introduced into Li7HM cells by MMCT as described previously (Ohmura et al., 1995; Tanaka et al., 1998) .
Measurement of in vitro population doublings of microcell hybrid clones
The number of population doublings at each passage was calculated from the formula n=Slog 2 (Ni/No), where n=number of population doublings, Ni=cell yield and No=number of seeded cells. Two or more clones (for each chromosome or chromosomal fragment) were measured at 10-day intervals for 4 months.
Telomeric repeat amplification protocol (TRAP) assay and terminal restriction fragment (TRF) length analysis
Telomerase activity was measured using the TRAP method as described by Kim et al. (1994) . PCR products were resolved on a 10% polyacrylamide gel. TRF length was measured by Southern blot hybridization as described by Harley et al. (1990) .
Fluorescence in situ hybridization (FISH)
The hybridization protocol followed that of Cherif et al. (1989) , with slight modi®cations (Uejima et al., 1995) . The pSV2bsr plasmid was used as a probe.
Chromosomal in situ suppression (CISS) hybridization
For CISS hybridization, either a human chromosome 10p, 10p fragment in mouse A9 cells or a human chromosome 2 and 10 cells. Lysis buer was used as a negative control (L.B.). B1-1, B1-2 and B1-3; microcell hybrid clones containing a B1 fragment. D6-1; microcell hybrid clone containing a D6 fragment. B18-1; microcell hybrid clone containing a B18 fragment. E and L; early passage (less than 30 PDs) and late passage (more than 100 PDs). This assay uses PCR to amplify the products of telomerase-catalyzed extension of an oligonucleotide primer in the presence of ®ve attograms of an internal TRAP assay standard (ITAS) (Wright et al., 1995) . (b) Southern blot analyses of TRF lengths in parental Li7HM cells and microcell hybrids containing human chromosome 10p15. The band in the vicinity of 23 kb that was detected in Li7HM (B1) hybrids was considered to be derived from Chinese hamster DNA, because this was observed in controls using CHO cell DNA (data not shown). Population doublings (PDs) are indicated above the lanes. Size markers are indicated on the left Figure 7 Expression analyses of hTERT, hTR and TEP1 by RT ± PCR. Product sizes are indicated on the right. A control cDNA reaction without reverse transcriptase (RTase) was performed for each sample. Expression of G3PDH was determined as a control for RNA integrity. NHF: normal human ®broblast Oncogene Telomerase repressor gene on 10p15.1 A Nishimoto et al 10p15 fragment in Chinese hamster ovary (CHO) cells was ampli®ed speci®cally using the Alu-based PCR primers CL1 and/or CL2 according to the protocol of Lengauer et al. (1992) . The PCR products were fractionated by gel electrophoresis to verify chromosome 10p-speci®c ampli®ca-tion and used for FISH analysis with CISS using human Cot-1 DNA. In case of using the 10p15 fragment-derived product as a probe, the slides were mounted in antifade solution containing 0.2 mg/ml of 4', 6-diamidino-2-phenylindole (DAPI).
DNA analysis with STS markers
Genomic DNA for PCR templates was extracted by proteinase K digestion and phenol/chloroform extraction. One hundred ng of template DNA was used for PCR analysis. The PCR products were separated in a 5% polyacrylamide gel.
RNA expression
Total cellular RNAs were isolated from cultured cells using ISOGEN (Wako) according to the manufactures instructions and were treated with DNase I (Life Technologies, Inc.). Total RNA were reverse-transcribed using the SuperScript preampli®cation system for ®rst-strand cDNA synthesis (Life Technologies, Inc.). A part of the reaction (0.5 ml) was used as a template in 10 ml PCR ampli®cations using the Advantage cDNA PCR kit (Clontech). For hTR, the samples were subjected to 25 cycles of denaturation at 948C for 30 s and annealing/extention at 658C for 60 s with the primers 5'-CCTAACTGAGAAGGGCGTAGGC-3' and 5'-CTAGAAT-GAACGGTGGAAGGCG-3'. For TEP1, the samples were subjected to 30 cycles of 948C for 30 s and 628C for 45 s with the primers 5'-CTGTACGGCTCTGGCAGGT-3' and 5'-GGAGCCCAATCCAGACTTGT-3'. For ampli®cation of hTERT, the samples were subjected to 30 cycles of 948C for 30 s and 628C for 45 s with the primers 5'-CCTCTGTGCTGGGCCTGGACGATA-3' and 5'-ACGGCTGGAGGTCTGTCAAGGTAG-3'. For glyceraldehyde-3-phosphate dehydrogenase (G3PDH), the samples were subjected to 25 cycles of 948C for 30 s and 628C for 45 s with the primers 5'-ACCACAGTCCATGCCATCAC-3' and 5'-TCCACCACCCTGTTGCTGTA-3'. All the PCR products were analysed by gel electrophoresis in the appropriate percentage of agarose.
